Moran Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-206,374
| Closed | -$14.3M | – | 500 |
|
|
2025
Q1 | $14.3M | Sell |
206,374
-166,319
| -45% | -$11.5M | 0.48% | 66 |
|
|
2024
Q4 | $32.1M | Sell |
372,693
-56,942
| -13% | -$4.9M | 1.02% | 15 |
|
|
2024
Q3 | $51.2M | Sell |
429,635
-5,196
| -1% | -$619K | 1.57% | 4 |
|
|
2024
Q2 | $62.1M | Sell |
434,831
-5,319
| -1% | -$759K | 2.04% | 1 |
|
|
2024
Q1 | $56.5M | Sell |
440,150
-7,922
| -2% | -$1.02M | 1.83% | 1 |
|
|
2023
Q4 | $46.4M | Sell |
448,072
-2,524
| -0.6% | -$261K | 1.65% | 3 |
|
|
2023
Q3 | $41M | Sell |
450,596
-16,220
| -3% | -$1.48M | 1.59% | 2 |
|
|
2023
Q2 | $37.8M | Sell |
466,816
-23,858
| -5% | -$1.93M | 1.42% | 5 |
|
|
2023
Q1 | $39M | Sell |
490,674
-4,146
| -0.8% | -$330K | 1.48% | 3 |
|
|
2022
Q4 | $33.5M | Buy |
+494,820
| New | +$33.5M | 1.27% | 10 |
|